397 related articles for article (PubMed ID: 19491821)
1. Integration-deficient lentiviral vectors: a slow coming of age.
Wanisch K; Yáñez-Muñoz RJ
Mol Ther; 2009 Aug; 17(8):1316-32. PubMed ID: 19491821
[TBL] [Abstract][Full Text] [Related]
2. Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line.
Nordin F; Hamid ZA; Chan L; Farzaneh F; Hamid MK
Methods Mol Biol; 2016; 1448():159-73. PubMed ID: 27317180
[TBL] [Abstract][Full Text] [Related]
3. Hybrid lentivirus-transposon vectors with a random integration profile in human cells.
Staunstrup NH; Moldt B; Mátés L; Villesen P; Jakobsen M; Ivics Z; Izsvák Z; Mikkelsen JG
Mol Ther; 2009 Jul; 17(7):1205-14. PubMed ID: 19240688
[TBL] [Abstract][Full Text] [Related]
4. A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells.
Vijayraghavan S; Kantor B
J Vis Exp; 2017 Dec; (130):. PubMed ID: 29286484
[TBL] [Abstract][Full Text] [Related]
5. Integrase-defective lentiviral vectors--a stage for nonviral integration machineries.
Staunstrup NH; Mikkelsen JG
Curr Gene Ther; 2011 Oct; 11(5):350-62. PubMed ID: 21745178
[TBL] [Abstract][Full Text] [Related]
6. Efficient gene expression from integration-deficient lentiviral vectors in the spinal cord.
Peluffo H; Foster E; Ahmed SG; Lago N; Hutson TH; Moon L; Yip P; Wanisch K; Caraballo-Miralles V; Olmos G; Lladó J; McMahon SB; Yáñez-Muñoz RJ
Gene Ther; 2013 Jun; 20(6):645-57. PubMed ID: 23076378
[TBL] [Abstract][Full Text] [Related]
7. Stable gene transfer to muscle using non-integrating lentiviral vectors.
Apolonia L; Waddington SN; Fernandes C; Ward NJ; Bouma G; Blundell MP; Thrasher AJ; Collins MK; Philpott NJ
Mol Ther; 2007 Nov; 15(11):1947-54. PubMed ID: 17700544
[TBL] [Abstract][Full Text] [Related]
8. Improving the Transduction of Bone Marrow-Derived Cells with an Integrase-Defective Lentiviral Vector.
Pay SL; Qi X; Willard JF; Godoy J; Sankhavaram K; Horton R; Mitter SK; Quigley JL; Chang LJ; Grant MB; Boulton ME
Hum Gene Ther Methods; 2018 Feb; 29(1):44-59. PubMed ID: 29160102
[TBL] [Abstract][Full Text] [Related]
9. Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk.
Chick HE; Nowrouzi A; Fronza R; McDonald RA; Kane NM; Alba R; Delles C; Sessa WC; Schmidt M; Thrasher AJ; Baker AH
Hum Gene Ther; 2012 Dec; 23(12):1247-57. PubMed ID: 22931362
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk.
Mátrai J; Cantore A; Bartholomae CC; Annoni A; Wang W; Acosta-Sanchez A; Samara-Kuko E; De Waele L; Ma L; Genovese P; Damo M; Arens A; Goudy K; Nichols TC; von Kalle C; L Chuah MK; Roncarolo MG; Schmidt M; Vandendriessche T; Naldini L
Hepatology; 2011 May; 53(5):1696-707. PubMed ID: 21520180
[TBL] [Abstract][Full Text] [Related]
11. Non-integrating lentiviral vectors.
Sarkis C; Philippe S; Mallet J; Serguera C
Curr Gene Ther; 2008 Dec; 8(6):430-7. PubMed ID: 19075626
[TBL] [Abstract][Full Text] [Related]
12. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.
Philippe S; Sarkis C; Barkats M; Mammeri H; Ladroue C; Petit C; Mallet J; Serguera C
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17684-9. PubMed ID: 17095605
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells.
Pelascini LP; Janssen JM; Gonçalves MA
Hum Gene Ther; 2013 Jan; 24(1):78-96. PubMed ID: 23140481
[TBL] [Abstract][Full Text] [Related]
14. Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors.
Okada Y; Ueshin Y; Hasuwa H; Takumi K; Okabe M; Ikawa M
Genesis; 2009 Apr; 47(4):217-23. PubMed ID: 19208434
[TBL] [Abstract][Full Text] [Related]
15. Sleeping beauty transposition from nonintegrating lentivirus.
Vink CA; Gaspar HB; Gabriel R; Schmidt M; McIvor RS; Thrasher AJ; Qasim W
Mol Ther; 2009 Jul; 17(7):1197-204. PubMed ID: 19417741
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the impact of parameters influencing transgene expression kinetics after repeated cell transduction with integration-deficient retroviral vectors.
Schott JW; Jaeschke NM; Hoffmann D; Maetzig T; Ballmaier M; Godinho T; Cathomen T; Schambach A
Cytometry A; 2015 May; 87(5):405-18. PubMed ID: 25728583
[TBL] [Abstract][Full Text] [Related]
17. Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's disease.
Lu-Nguyen NB; Broadstock M; Schliesser MG; Bartholomae CC; von Kalle C; Schmidt M; Yáñez-Muñoz RJ
Hum Gene Ther; 2014 Jul; 25(7):631-41. PubMed ID: 24635742
[TBL] [Abstract][Full Text] [Related]
18. One-year follow-up of transgene expression by integrase-defective lentiviral vectors and their therapeutic potential in spinocerebellar ataxia model mice.
Saida H; Matsuzaki Y; Takayama K; Iizuka A; Konno A; Yanagi S; Hirai H
Gene Ther; 2014 Sep; 21(9):820-7. PubMed ID: 24989813
[TBL] [Abstract][Full Text] [Related]
19. Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase.
Moldt B; Staunstrup NH; Jakobsen M; Yáñez-Muñoz RJ; Mikkelsen JG
BMC Biotechnol; 2008 Aug; 8():60. PubMed ID: 18691430
[TBL] [Abstract][Full Text] [Related]
20. Integrase-defective lentiviral vectors as a delivery platform for targeted modification of adenosine deaminase locus.
Joglekar AV; Hollis RP; Kuftinec G; Senadheera S; Chan R; Kohn DB
Mol Ther; 2013 Sep; 21(9):1705-17. PubMed ID: 23857176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
